Home
News
Latest News
People Moves
Business Briefs
Newsletters
Features
Features
Reprints
Surveys
Editorial Calendar
Web Exclusives
Issue Archive
Events
MM&M Awards 2012
txt4pharma
MM&M Virtual Summit
Webcasts
Leadership Exchanges
Whitepapers
Directories
Creative Portfolio
Mobile Guide
Interactive Guide
Pharmaceutical Marketers Directory
MM&M Service Directory
Agency Gallery
Direct Marketing Showcase
Medical Education Review
Sales Force Listings
Jobs
About Us
Subscriber Services
Contact Us
Media Information
Editorial Advisory Board
Drug Info
New Drug Dossier
Drug Database
Subscribe
Order Now
Subscriber Services
Newsletters
RSS
|
Login
|
Register
MMM
>
Issue Archive
> October 2008 Issue of MMM
October 2008 43 10 Issue of MMM
Editor's Desk
Power isn't knowledge
Patient marketers and industry commentators talk an awful lot about the "empowered" consumer.
Features
The Age of Engagement
There's more to patient programs than simply telling folks what to do. Ben Comer looks at ways to drive actions
Social Etiquette
Just as it followed other sectors into CRM, the pharma industry must find entry points into the online patient conversation. Gil Bashe explores some of ...
Data-Driven DTP
Utilizing an effective marketing strategy can go a long way in maximizing the lifetime value of a pharmaceutical brand. Harte-Hanks' Julian Parreno looks at how ...
Poll Reversal
It's an Alice in Wonderland election for the industry, which finds itself favoring the Democratic candidate after eight years of alignment with the party of ...
Medical/Surgical Journal Ad Review
With the lowest first-half spend since 2003, the top journals are left wondering if their luck will ever turn around. Eugene M. May reports on ...
Headliner: AngioGenex's William A. Garland, PhD
After nearly 20 years at Hoffmann-La Roche, William A. Garland, PhD, left big pharma in 1994 to direct research and development for a number of ...
Antidote
Antidote
Diabetes is a tough disease to treat.
Med Ed Report
CME commercial support flat in '07
Total commercial support of CME scarcely budged in 2007, rising 1% to $1.2 billion, while the share of commercial support going to publishing and education ...
GSK joins the grant reporting game
GlaxoSmithKline will join Pfizer and Eli Lilly in reporting its educational and charitable grants.
IMAP launches COI database
The Institute on Medicine as a Profession launched its IMAP AMC Conflict of Interest Policy Data Base, purporting to show academic medical centers' ties to ...
Professional Media
Medical Economics overhauls team
Advanstar's Medical Economics title announced the hiring of new senior-level editors.
Endocrine Daily Briefing unveiled
BulletinNews, a customized publisher service for professional associations, has launched Endocrine Daily Briefing.
Media Forum
Balancing messages on- and offline
Effective patient marketing campaigns utilize traditional DTC as well as social networks and other emerging media online. How do marketers find the right media balance?
Direct Marketing
Zomig promo gives doctors the 'key'
Finding new and innovative ways to communicate valuable information to healthcare professionals is an ongoing challenge for pharma companies.
Manhattan Research lists top sites
Two diabetes product sites, Merck's Januvia and Takeda's Actos, came in first and second, respectively, in a new study measuring physicians' web habits.
Sciele takeover nets veteran reps
With its acquisition of Sciele Pharma, Osaka, Japan-based Shionogi & Co. will gain immediate entry into the US pharmaceutical market and inherit 720 seasoned sales ...
DTC Report
Ads in Canada had little impact: study
A study of how DTC TV advertising impacted different populations in Canada suggested that ads may have little impact on consumers.
FDA posts DTC guide on its site
FDA posted a guide to drug advertising on its site for consumers, "Be smart about prescription drug advertising."
Digital Media
Web Watch
Physicians are busy.
SearchMedica adds new component
Searchmedica.com, a free search engine for physicians and medical practioners, has launched a new practice management category.
Public Relations
PR View by Diane Weiser
This year has not been kind to biopharmaceutical companies.
Fleishman-Hillard wins Siemens assignment
Fleishman-Hillard has won an AOR assignment for Siemens Medical System's AG's global health division.
Senetek PLC taps Michael Rogers PR
Senetek PLC, a life sciences company focused on anti-aging technologies, has tapped Michael Rogers PR for the launch of its Pyratine-6 product.
Marketing Research
Vantage Point
I finally broke down and bought the new iPhone 3G.
Decision Resources Inc. unveils 'cohesive' site
In an effort to create a more cohesive online experience for its potential clients, Decision Resources Inc. launched www.DecisionResourcesInc.com.
Panel to offer data from 18,000 docs
All Global, an international healthcare data collection agency, launched a Palliative Care Panel for marketing research.
CapMed: health records are not created equal
Consumer personal health records (PHR) are more than just a storage space for electronic health records.
Washington Insider
As I see it
Although feelings in the mainstream drug industry will be mixed, it's time to end the secrecy that surrounds the FDA's decision-making on approving drugs.
As I see it
Although feelings in the mainstream drug industry will be mixed, it's time to end the secrecy that surrounds the FDA's decision-making on approving drugs.
GAO: FDA's Mifeprex approval 'consistent'
The Government Accountability Office said the FDA's approval process for Mifeprex, the RU-486 abortion pill, was "consistent with the processes for the other Subpart H ...
Lawyers defend failure-to-warn suit
Attorneys for a woman who lost an arm to gangrene after an IV administration of Wyeth's anti-nausea drug Phenergan say there is no conflict between ...
Kennedy, Kessler fight pre-emption
Former FDA commissioners Donald Kennedy and David Kessler have told the Supreme Court that drug company and FDA arguments promoting FDA pre-emption of state failure-to-warn ...
Drug testing puts consumers at risk
A sociologist says fatal flaws in the way new drugs are tested and marketed mean that American consumers are likely to be exposed to unacceptable ...
Back Talk
Mr. H and the rallying cry
Recently I had the distinct honor of delivering the keynote address for the Doctors' Choice Awards, an event sponsored by the Association of Medical Media.
Video Exclusive
Web Exclusives
Five industry experts advise specialty pharma company on digital strategy
April 20, 2012
Specialty pharma company POZEN assembled a crack team of experts to help shape its digital strategy. Not only did POZEN share with us the text from their contributions, but you can watch exclusive video clips of their valuable perspectives right here.
MM&M Awards 2011 HIghlights
The Best MM&M Awards Ever!
MAHF Ceremony 2012
Photos from the Medical Advertising Hall of Fame Awards ceremony
Most Popular
Most Emailed
Most Recent
Humira on solid ground, analysts say, despite vote on Pfizer hopeful
Goodbye Plavix, hello competition
Sales forces shrank in 2011, but not everywhere
Wolters Kluwer deals health analytics unit to private equity firm
RX-to-OTC proposal gets mixed reviews
Pharmas are from Mars, Payers are from Venus
No-see docs are know-nothings when it comes to new drug info, study suggests
Study: Young Latinas are key decision makers, prefer English
How CDC's hep.-C testing advice benefits drugmakers now
Coach vs. cancer in BMS-backed awareness effort
Harvard urges faculty to ditch journals
Study: Young Latinas are key decision makers, prefer English
Pharma Report 2012: Get Back in Shape
Massachusetts gift ban under attack (again)
Pfizer, Crestor tops for global promotional spend in 2011
Novo Nordisk plans US hiring spree as Q1 sales jump 10%
Med Ed Report: Show Me the Money
No-see docs are know-nothings when it comes to new drug info, study suggests
Wolters Kluwer deals health analytics unit to private equity firm
Humira on solid ground, analysts say, despite vote on Pfizer hopeful
Did FDA's Vytorin warning negatively impact health outcomes?
Roundtable outlines path for publisher, pharma credibility
No-see docs are know-nothings when it comes to new drug info, study suggests
E-prescriptions boost adherence data
How CDC's hep.-C testing advice benefits drugmakers now
PhRMA's Washington wish list
Study: Young Latinas are key decision makers, prefer English
Pharmas are from Mars, Payers are from Venus
Goodbye Plavix, hello competition
Indian conglomerate buys Manhattan Research parent for $635m
Popular Topics
Acquisition
Adherence
App
Celebrity
Clinical Trial
Co-Marketing
Diabetes
Diagnostics
Digital
Direct To Consumer (DTC)
Disease Awareness
Downsize
Education & Awareness
FDA
Government
Guidance
Health Plans
HMOs
Hospitals
Insurers
Law
Marketing Research
Medical Journal
Mobile
Sales Force